Ascendis Pharma competitive analysis

Latest publications and patents of Ascendis Pharma New

Explore the latest publications and patents granted to Ascendis Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ascendis Pharma

Feb 7, 2018Dry Growth Hormone Composition Transiently Linked To A Polymer CarrierNo Opposition Filed Within Time Limit

Explore patent oppositions filed by Ascendis Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALApr 10, 2025
Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICALSep 1, 2022

Latest PTAB cases involving Ascendis Pharma

Discover the latest PTAB cases involving Ascendis Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ascendis Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ASCENDIS PHARMA GROWTH DISORDERS1 - - - Highly Aggressive
BIOMARIN PHARMACEUTICAL - 183 - Defensive